Marksans Pharma Ltd. — Call Transcript 2024

Nov 5, 2024

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

November 05, 2024

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department PhirozeJeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS

Subject: Intimation of schedule for Q2FY25 Earnings Conference Call

Dear Sir/Madam,

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled a conference call for analysts and investors on Wednesday, November 13, 2024 at 05:00 p.m. (IST) to discuss the Unaudited (standalone and consolidated) financial results of the Company for the quarter and half year ended September 30, 2024.

The details and schedule with respect to the conference call is enclosed herewith.

The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/investors-presentation.html.

We request you to take the aforesaid on your records.

Thanking you.

Yours faithfully,

For Marksans Pharma Limited

Digitally signed by HARSHAVARDH HARSHAVARDHAN PANIGRAHI AN PANIGRAHI Date: 2024.11.05 17:27:00 +05'30'

Harshavardhan Panigrahi Company Secretary

Encl: As below

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [143 x 39] intentionally omitted <==

==> picture [93 x 48] intentionally omitted <==

Earnings Conference Call

Elara Securities (India) Private Limited is pleased to invite you to a Conference Call with

Marksans Pharma Limited

CIN: L24110MH1992PLC066364

represented by

Mr. Mark Saldanha , Founder, Chairman, and Managing Director

Mr. Jitendra Sharma, Chief Financial Officer

Subject: Conference call to discuss Q2FY25 earnings

Date: Wednesday, 13 November, 2024

Time: 05.00 PM IST

11.30 AM (UK) - 07.30 PM (Singapore, Hong Kong) 06.30 AM (East Coast, US) - 03.30 AM (West Coast, US)

Diamond Pass Login: click here for Registration

Dial in Numbers:

Universal Numbers +91 22 6280 1146 +91 22 7115 8047

Toll Free Numbers US: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 Australia: 1800053698

RSVP Dr. Bino Pathiparampil I bino.pathiparampil@elaracapital.com I +91 22 6164 8689

India Europe USA Elara Securities (India) Private Limited Elara Capital Plc. Elara Securities Inc. One International Center, Tower 3, 6th Floor, The Grove, 230 Park Avenue, Suite 2415, 21st Floor, Senapati Bapat Marg, 248A Marylebone Road, New York, NY 10169, USA Elphinstone Road (West) London, NW1 6JZ, Tel: +1 212 430 5870 Mumbai – 400 013, India United Kingdom Fax: +1 212 208 2501 Tel : +91 22 6164 8500 Tel : +44 20 7486 9733

Asia / Pacific Elara Capital (Asia) Pte.Ltd. One Marina Boulevard, Level 20, Singapore 018989 Tel : +65 6978 4047